 | Up a level |
Journal Article
Carter, Daniel R., Murray, Jayne, Cheung, Belamy B., Gamble, Laura, Koach, Jessica, Tsang, Joanna, Sutton, Selina, Kalla, Heyam, Syed, Sarah, Gifford, Andrew J., Issaeva, Natalia 
ORCID: 0000-0001-5483-6610, Biktasova, Asel, Atmadibrata, Bernard, Sun, Yuting, Sokolowski, Nicolas, Ling, Dora, Kim, Patrick Y., Webber, Hannah, Clark, Ashleigh, Ruhle, Michelle, Liu, Bing, Oberthuer, Andre, Fischer, Matthias, Byrne, Jennifer, Saletta, Federica ORCID: 0000-0003-0598-3504, Thwe, Le Myo, Purmal, Andrei, Haderski, Gary, Burkhart, Catherine, Speleman, Frank, De Preter, Katleen, Beckers, Anneleen, Ziegler, David S., Liu, Tao ORCID: 0000-0001-6244-7316, Gurova, Katerina V., Gudkov, Andrei V., Norris, Murray D., Haber, Michelle ORCID: 0000-0003-2036-8817 and Marshall, Glenn M.
(2015).
Therapeutic targeting of the MYC signal by inhibition of histone chaperone FACT in neuroblastoma.
Sci. Transl. Med., 7 (312).
WASHINGTON:
AMER ASSOC ADVANCEMENT SCIENCE.
ISSN 1946-6242
Haber, Michelle, Murray, Jayne, Gamble, Laura, Carnegie-Clark, Ashleigh, Webber, Hannah, Ruhle, Michelle, Henderson, Michelle J., Middlemass, Shiloh, Carter, Daniel, Tsoli, Maria, Ehteda, Anahid, Simon, Sandy, Oberthuer, Andre, Fischer, Matthias, Gurova, Katerina, Burkhart, Catherine, Purmal, Andrei, Lock, Richard B., Ziegler, David, Marshall, Glenn M., Gudkov, Andrei V. and Norris, Murray D. (2015). The FACT histone chaperone complex is highly expressed in aggressive drug refractory childhood cancers and the anti-FACT compound CBL0137 represents a highly promising therapeutic approach in this setting. Cancer Res., 75. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. ISSN 1538-7445